STOCK TITAN

Ambiq Micro Financials

AMBQ
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Ambiq Micro (AMBQ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMBQ FY2025

AMBQ is operating as a cash-funded development business where fresh financing, not current sales, carries the model.

Over the last two annual periods, the balance sheet moved from negative equity to positive equity and cash rose to $140.3M, even though operating cash flow was still -$19.7M. That combination means the stronger-looking capital position came from financing inflows, not from the business suddenly turning its reported losses into cash.

Gross margin expanded from 31.9% to 44.3%, but operating margin stayed deeply negative because R&D and overhead still sat above gross profit. Since sales were lower in the newer year, that margin improvement points more to cost or mix change than to simple scale absorption.

Operating cash outflow improved only slightly, moving from -$21.4M to -$19.7M. Because cash burn and reported losses stayed broadly aligned, the deficit looks structural to the present operating model rather than mainly a temporary working-capital swing. That usually means customers and suppliers are not yet providing a meaningful cash cushion.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 43 / 100
Financial Health Score 43/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ambiq Micro's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
38

Ambiq Micro has an operating margin of -54.5%, meaning the company retains $-55 of operating profit per $100 of revenue. This results in a moderate score of 38/100, indicating healthy but not exceptional operating efficiency. This is down from -53.4% the prior year.

Growth
19

Ambiq Micro's revenue declined 4.7% year-over-year, from $76.1M to $72.5M. This contraction results in a growth score of 19/100.

Leverage
78

Ambiq Micro carries a low D/E ratio of 0.14, meaning only $0.14 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
96

With a current ratio of 8.76, Ambiq Micro holds $8.76 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 96/100.

Returns
28

Ambiq Micro generates a -22.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 28/100.

Altman Z-Score Safe
42.46

Ambiq Micro scores 42.46, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.6B) relative to total liabilities ($22.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Ambiq Micro passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality
0.54x

For every $1 of reported earnings, Ambiq Micro generates $0.54 in operating cash flow (-$19.7M OCF vs -$36.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$72.5M
YoY-4.7%

Ambiq Micro generated $72.5M in revenue in fiscal year 2025. This represents a decrease of 4.7% from the prior year.

EBITDA
-$32.3M
YoY+5.9%

Ambiq Micro's EBITDA was -$32.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.9% from the prior year.

Net Income
-$36.5M
YoY+8.1%

Ambiq Micro reported -$36.5M in net income in fiscal year 2025. This represents an increase of 8.1% from the prior year.

EPS (Diluted)
$-4.57

Ambiq Micro earned $-4.57 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$140.3M
YoY+130.0%

Ambiq Micro held $140.3M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
18M

Ambiq Micro had 18M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
44.3%
YoY+12.3pp

Ambiq Micro's gross margin was 44.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 12.3 percentage points from the prior year.

Operating Margin
-54.5%
YoY-1.1pp

Ambiq Micro's operating margin was -54.5% in fiscal year 2025, reflecting core business profitability. This is down 1.1 percentage points from the prior year.

Net Margin
-50.3%
YoY+1.9pp

Ambiq Micro's net profit margin was -50.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.9 percentage points from the prior year.

Return on Equity
-22.4%

Ambiq Micro's ROE was -22.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending
$38.5M
YoY+3.5%

Ambiq Micro invested $38.5M in research and development in fiscal year 2025. This represents an increase of 3.5% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

AMBQ Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $25.1M+20.8% $20.7M+14.2% $18.2M+1.6% $17.9M+13.6% $15.7M N/A $20.3M+0.1% $20.3M
Cost of Revenue $14.2M+19.2% $11.9M+13.3% $10.5M-2.0% $10.7M+45.8% $7.3M N/A $13.7M-1.2% $13.8M
Gross Profit $10.9M+22.9% $8.9M+15.4% $7.7M+7.1% $7.2M-14.5% $8.4M N/A $6.6M+2.9% $6.4M
R&D Expenses $12.8M+6.8% $12.0M+35.1% $8.9M-0.1% $8.9M+2.4% $8.7M N/A $9.6M+1.9% $9.4M
SG&A Expenses $9.7M+10.7% $8.8M-0.2% $8.8M+24.9% $7.1M-16.3% $8.4M N/A $7.1M-10.8% $8.0M
Operating Income -$11.7M+2.3% -$12.0M-19.1% -$10.0M-14.2% -$8.8M-0.6% -$8.7M N/A -$10.1M+8.0% -$11.0M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $3K-84.2% $19K+533.3% $3K-78.6% $14K+250.0% $4K N/A $13K+85.7% $7K
Net Income -$10.2M+4.8% -$10.7M-18.6% -$9.0M-6.0% -$8.5M-2.6% -$8.3M N/A -$9.4M+11.2% -$10.6M
EPS (Diluted) $-0.50 N/A $-0.72 $-18.89+0.4% $-18.96 N/A $-26.03+24.7% $-34.59

AMBQ Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $259.5M+40.5% $184.7M-1.1% $186.7M+109.4% $89.2M N/A $104.3M N/A N/A
Current Assets $241.7M+43.9% $167.9M-2.9% $173.0M+131.0% $74.9M N/A $89.0M N/A N/A
Cash & Equivalents $204.5M+45.8% $140.3M-4.2% $146.5M+208.4% $47.5M N/A $61.0M N/A N/A
Inventory $23.5M+38.5% $16.9M+5.0% $16.1M+2.3% $15.8M N/A $15.0M N/A N/A
Accounts Receivable $11.0M+50.6% $7.3M+4.0% $7.0M-10.0% $7.8M N/A $10.4M N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $24.4M+9.6% $22.2M+31.2% $16.9M-95.7% $396.5M N/A $396.7M N/A N/A
Current Liabilities $20.6M+7.7% $19.2M+44.6% $13.3M-0.7% $13.4M N/A $11.8M N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $235.2M+44.7% $162.5M-4.3% $169.8M+155.2% -$307.3M-2.5% -$299.7M-2.5% -$292.4M-3.0% -$283.8M-2.6% -$276.6M
Retained Earnings -$366.9M-2.9% -$356.7M-3.1% -$346.0M-2.7% -$337.0M N/A -$320.3M N/A N/A

AMBQ Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$11.2M-171.7% -$4.1M+18.2% -$5.0M+57.9% -$12.0M-950.3% $1.4M+409.4% $276K+101.7% -$16.6M N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$4.0M-55.0% -$2.6M-51.9% -$1.7M+15.7% -$2.0M-81.5% -$1.1M+16.9% -$1.3M-100.4% -$670K N/A
Financing Cash Flow $79.4M+16246.5% $486K-99.5% $105.7M+391466.7% $27K-81.8% $148K-71.0% $511K-92.2% $6.5M N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

AMBQ Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 43.5%+0.8pp 42.7%+0.5pp 42.3%+2.1pp 40.1%-13.2pp 53.3% N/A 32.6%+0.9pp 31.7%
Operating Margin -46.6%+11.0pp -57.7%-2.4pp -55.3%-6.1pp -49.2%+6.3pp -55.6% N/A -49.8%+4.3pp -54.1%
Net Margin -40.6%+10.9pp -51.5%-1.9pp -49.6%-2.0pp -47.5%+5.1pp -52.7% N/A -46.6%+5.9pp -52.5%
Return on Equity -4.3%+2.2pp -6.6%-1.3pp -5.3% N/A N/A N/A N/A N/A
Return on Assets -3.9%+1.9pp -5.8%-1.0pp -4.8%+4.7pp -9.5% N/A N/A N/A N/A
Current Ratio 11.70+2.9 8.76-4.3 13.04+7.4 5.60 N/A 7.56 N/A N/A
Debt-to-Equity 0.10-0.0 0.14+0.0 0.10 N/A N/A N/A N/A N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Ambiq Micro (AMBQ) reported $72.5M in total revenue for fiscal year 2025. This represents a -4.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Ambiq Micro (AMBQ) revenue declined by 4.7% year-over-year, from $76.1M to $72.5M in fiscal year 2025.

No, Ambiq Micro (AMBQ) reported a net income of -$36.5M in fiscal year 2025, with a net profit margin of -50.3%.

Ambiq Micro (AMBQ) reported diluted earnings per share of $-4.57 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ambiq Micro (AMBQ) had EBITDA of -$32.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Ambiq Micro (AMBQ) had a gross margin of 44.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Ambiq Micro (AMBQ) had an operating margin of -54.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Ambiq Micro (AMBQ) had a net profit margin of -50.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ambiq Micro (AMBQ) has a return on equity of -22.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Ambiq Micro (AMBQ) generated -$19.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Ambiq Micro (AMBQ) had $184.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Ambiq Micro (AMBQ) invested $38.5M in research and development during fiscal year 2025.

Ambiq Micro (AMBQ) had 18M shares outstanding as of fiscal year 2025.

Ambiq Micro (AMBQ) had a current ratio of 8.76 as of fiscal year 2025, which is generally considered healthy.

Ambiq Micro (AMBQ) had a debt-to-equity ratio of 0.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ambiq Micro (AMBQ) had a return on assets of -19.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Ambiq Micro (AMBQ) had $140.3M in cash against an annual operating cash burn of $19.7M. This gives an estimated cash runway of approximately 85 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Ambiq Micro (AMBQ) has an Altman Z-Score of 42.46, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Ambiq Micro (AMBQ) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ambiq Micro (AMBQ) has an earnings quality ratio of 0.54x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ambiq Micro (AMBQ) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top